Original Source(s)
Related Content
TOFA may drive weight loss without reducing food intake
The oral compound increased energy expenditure, reduced fat mass, and improved metabolic measures in male mouse models.
August 27, 2026
-
4 min
Tirzepatide’s cardiovascular effects in clinical practice
Investigators compared cardiovascular outcomes with tirzepatide and a placebo proxy in patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
August 28, 2026
-
4 min
FDA monthly preview: Key September decisions to watch
Several FDA decisions across multiple specialties are expected this month.
August 28, 2026
-
5 min
